Chagas Disease

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Neglected Tropical Diseases

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/3-540-29668-9_534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Major benznidazole metabolites in patients treated for Chagas disease: mass spectrometry-based identification, structural analysis and detoxification pathways.

  2023cited by this paper
• Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults

  2022cited by this paper
• Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2001–2021

  2022cited by this paper
• Recommendations for Screening and Diagnosis of Chagas Disease in the United States

  2021influential reference
• Risk factors for vertical transmission of Chagas disease: A systematic review and meta-analysis

  2021cited by this paper
• Reactivation of Chagas Disease in a Patient With an Autoimmune Rheumatic Disease: Case Report and Review of the Literature

  2021cited by this paper
• WHF IASC Roadmap on Chagas Disease

  2020cited by this paper
• Epidemiology of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in the Americas: systematic review and meta‐analysis

  2020cited by this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cited by this paper
• Assessing the effectiveness of Chagas disease education for healthcare providers in the United States

  2020cited by this paper
• Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole

  2020cited by this paper
• Autochthonous Chagas Disease in the United States: How Are People Getting Infected?

  2020cited by this paper
• American trypanosomiasis (Chagas disease) in solid organ transplantation

  2020cited by this paper
• Contemporary Autochthonous Human Chagas Disease in the USA.

  2020cited by this paper
• Prevalence of Chagas Disease Among Family Members of Previously Diagnosed Patients in Los Angeles, California

  2019cited by this paper
• Evaluation and Management of Congenital Chagas Disease in the United States.

  2019cited by this paper
• Current Gaps and Needs for Increasing Access to Healthcare for People with Chagas Disease in the USA

  2019cited by this paper
• Epidemiology of Chagas Disease in the USA: High-Risk Patient Populations for Screening

  2019cited by this paper
• Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment

  2019cited by this paper
• Chagas Disease in the United States: a Public Health Approach

  2019cited by this paper
• Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States

  2019cited by this paper
• Chagas Disease Serological Test Performance in U.S. Blood Donor Specimens

  2019cited by this paper
• Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018

  2018cited by this paper
• “It’s Like a Phantom Disease”: Patient Perspectives on Access to Treatment for Chagas Disease in the United States

  2018cited by this paper
• The rise of neglected tropical diseases in the "new Texas"

  2018cited by this paper
• Congenital Chagas disease: current diagnostics, limitations and future perspectives

  2018cited by this paper
• Congenital Chagas Disease in the United States: Cost Savings through Maternal Screening

  2018cited by this paper
• Clinical and pharmacological profile of benznidazole for treatment of Chagas disease

  2018cited by this paper
• Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study

  2018cited by this paper
• Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management A Scientific Statement From the American Heart Association

  2018cited by this paper
• Ageing with Chagas disease: an overview of an urban Brazilian cohort in Rio de Janeiro

  2018cited by this paper
• Chagas Disease Surveillance Activities — Seven States, 2017

  2018cited by this paper
• Trypanosoma cruzi Transmission Among Captive Nonhuman Primates, Wildlife, and Vectors

  2018cited by this paper
• Analysis of over 1500 triatomine vectors from across the US, predominantly Texas, for Trypanosoma cruzi infection and discrete typing units.

  2018cited by this paper
• Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.

  2018cited by this paper
• Prevalence of Chagas Disease in the Latin American–born Population of Los Angeles

  2017cited by this paper
• Bionomics and Spatial Distribution of Triatomine Vectors of Trypanosoma cruzi in Texas and Other Southern States, USA

  2017cited by this paper
• The Prevalence of Chagas Disease Among Latin American Immigrants with Pacemakers in Los Angeles, California.

  2017cited by this paper
• Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.

  2017cited by this paper
• Survey of Pediatric Infectious Diseases Society Members About Congenital Chagas Disease

  2017cited by this paper
• Widespread Trypanosoma cruzi infection in government working dogs along the Texas-Mexico border: Discordant serology, parasite genotyping and associated vectors

  2017cited by this paper
• Prevalence of Chagas Disease in a U.S. Population of Latin American Immigrants with Conduction Abnormalities on Electrocardiogram

  2017cited by this paper
• Likely Autochthonous Transmission of Trypanosoma cruzi to Humans, South Central Texas, USA

  2017cited by this paper
• Epidemiology and Molecular Typing of Trypanosoma cruzi in Naturally-Infected Hound Dogs and Associated Triatomine Vectors in Texas, USA

  2017cited by this paper
• Is coverage enough? Persistent health disparities in marginalised Latino border communities

  2017cited by this paper
• Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease

  2017cited by this paper
• Diagnosis and Treatment of Congenital Chagas Disease in a Premature Infant.

  2016cited by this paper
• Commercial enzyme-linked immunosorbent assay versus polymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis

  2016cited by this paper
• What Do We Know About Chagas Disease in the United States?

  2016cited by this paper
• Over Six Thousand Trypanosoma cruzi Strains Classified into Discrete Typing Units (DTUs): Attempt at an Inventory

  2016cited by this paper
• Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States

  2016cited by this paper
• Estimating the Burden of Chagas Disease in the United States

  2016cited by this paper
• One Health Interactions of Chagas Disease Vectors, Canid Hosts, and Human Residents along the Texas-Mexico Border

  2016cited by this paper
• Access to care for Chagas disease in the United States: a health systems analysis.

  2015cited by this paper
• Prevalence of Chagas Disease in Latin-American Migrants Living in Europe: A Systematic Review and Meta-analysis

  2015cited by this paper
• Controlled but not cured: Structural processes and explanatory models of Chagas disease in tropical Bolivia.

  2015cited by this paper
• Chagas' Disease.

  2015cited by this paper
• Evidence of autochthonous Chagas disease in southeastern Texas.

  2015cited by this paper
• Chagas disease in Latin America: an epidemiological update based on 2010 estimates.

  2015cited by this paper
• Perinatal Screening for Chagas Disease in Southern Texas.

  2015cited by this paper
• Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.

  2015cited by this paper
• Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease

  2015cited by this paper
• Combining Public Health Education and Disease Ecology Research: Using Citizen Science to Assess Chagas Disease Entomological Risk in Texas

  2015cited by this paper
• Historical Perspectives on the Epidemiology of Human Chagas Disease in Texas and Recommendations for Enhanced Understanding of Clinical Chagas Disease in the Southern United States

  2015cited by this paper
• Trypanosoma cruzi screening in Texas blood donors, 2008–2012

  2014cited by this paper
• Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report.

  2014cited by this paper
• The history of Chagas disease

  2014cited by this paper
• Shelter Dogs as Sentinels for Trypanosoma cruzi Transmission across Texas

  2014cited by this paper
• Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

  2014cited by this paper
• Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas

  2014cited by this paper
• Systematic review: Prevalence of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in Brazil: a systematic review and meta‐analysis

  2014cited by this paper
• Chagas disease awareness among Latin American immigrants living in Los Angeles, California.

  2014cited by this paper
• Neglected Parasitic Infections in the United States: Chagas Disease

  2014cited by this paper
• Global economic burden of Chagas disease: a computational simulation model.

  2013cited by this paper
• Donor‐Derived Trypanosoma cruzi Infection in Solid Organ Recipients in the United States, 2001–2011

  2013cited by this paper
• Achievements and Challenges upon the Implementation of a Program for National Control of Congenital Chagas in Bolivia: Results 2004–2009

  2013cited by this paper
• Immunosuppression and Chagas Disease: A Management Challenge

  2013cited by this paper
• Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease

  2013cited by this paper
• Southern Plains Woodrats (Neotoma micropus) from Southern Texas Are Important Reservoirs of Two Genotypes of Trypanosoma cruzi and Host of a Putative Novel Trypanosoma Species

  2013cited by this paper
• Chagas disease in Latin American immigrants with dilated cardiomyopathy in New York City.

  2013cited by this paper
• Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS

  2013cited by this paper
• Diagnosis and management of Chagas disease and cardiomyopathy

  2012cited by this paper
• American trypanosomiasis (Chagas disease).

  2012cited by this paper
• Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach

  2012cited by this paper
• Undocumented immigrants and their use of medical services in Orange County, California.

  2012cited by this paper
• Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non‐endemic country

  2012cited by this paper
• Quality of life and depressive symptoms in Chagas disease patients

  2011cited by this paper
• Real-Time PCR in HIV/Trypanosoma cruzi Coinfection with and without Chagas Disease Reactivation: Association with HIV Viral Load and CD4+ Level

  2011cited by this paper
• Chagas disease in European countries: the challenge of a surveillance system.

  2011cited by this paper
• Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010).

  2011influential reference
• Guidelines on the Treatment of Chronic Coinfection by Trypanosoma cruzi and HIV Outside Endemic Areas

  2011influential reference
• Trypanosoma cruzi and Chagas' Disease in the United States

  2011cited by this paper
• "Kissing bugs": potential disease vectors and cause of anaphylaxis.

  2010cited by this paper
• Physician Awareness of Chagas Disease, USA

  2010cited by this paper
• Survey of obstetrician-gynecologists in the United States about Chagas disease.

  2010cited by this paper
• Chagas disease.

  2010cited by this paper
• Chagas Disease Risk in Texas

  2010cited by this paper
• Chagas disease in Spain, the United States and other non-endemic countries.

  2010cited by this paper
• Congenital transmission of Chagas disease: a clinical approach

  2010cited by this paper
• Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission.

  2009cited by this paper

• Epidemiological, clinical and etiological treatment aspects in the Chagas clinic of the municipality of Comapa - Jutiapa, Guatemala.

  2025cites this paper
• Repurposing COVID-19 Compounds (via MMV COVID Box): Almitrine and Bortezomib Induce Programmed Cell Death in Trypanosoma cruzi

  2025cites this paper
• Immunogenicity of Trypanosoma cruzi Multi-Epitope Recombinant Protein as an Antigen Candidate for Chagas Disease Vaccine in Humans

  2025cites this paper
• Congenital transmission of Chagas disease by vector circulation zone in Bolivia

  2025cites this paper
• Contemporary Management of Patients With Chagas Cardiomyopathy in Bolivia

  2025cites this paper
• The Pivotal Role of Cardiac Magnetic Resonance Imaging in Diagnosing Chronic Chagas Cardiomyopathy

  2025cites this paper
• Die Chagas-Erkrankung

  2025cites this paper
• Small-RNA sequencing identifies serum microRNAs associated with abnormal electrocardiography findings in patients with Chagas disease.

  2025cites this paper
• Chagas disease in Trinidad and Tobago – a call to action

  2025cites this paper
• Chagas Disease in Latin America and the United States: Factors Influencing Differences in Transmission Rates Among Differing Populations and Vectors

  2025influential citation
• Dual RNA-Seq Reveals Strain-Specific Transcriptional Adaptations of Trypanosoma cruzi in Host Cells Infected with Isolates from Acute and Chronic Cases.

  2025cites this paper
• Multimodal Cardiac Imaging of a Sudden Cardiac Death Survivor From Central America

  2025cites this paper
• Case Report: Reactivation of Chagas disease in a patient with advanced HIV 15 Years after migration

  2025cites this paper
• Immune Reactions of Vector Insects to Parasites and Pathogens

  2024cites this paper
• Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia.

  2024cites this paper
• Investigating the binding of fluorescent probes to a trypanosomal-tRNA synthetase: a fluorescence spectroscopic and molecular dynamics study.

  2024cites this paper
• Mapping the transporter-substrate interactions of the Trypanosoma cruzi NB1 nucleobase transporter reveals the basis for its high affinity and selectivity for hypoxanthine and guanine and lack of nucleoside uptake.

  2024cites this paper
• α-Glucosidase isoform G contributes to heme detoxification in Rhodnius prolixus and its knockdown affects Trypanosoma cruzi metacyclogenesis

  2024cites this paper
• PEX1 is essential for glycosome biogenesis and trypanosomatid parasite survival

  2024cites this paper
• Discovery of Strong 3-Nitro-2-Phenyl-2H-Chromene Analogues as Antitrypanosomal Agents and Inhibitors of Trypanosoma cruzi Glucokinase

  2024influential citation
• Unraveling the role of miRNAs as biomarkers in Chagas cardiomyopathy: Insights into molecular pathophysiology

  2024cites this paper
• Predictors of ischemic stroke in Chagas disease: Insights into mechanisms beyond cardiomyopathy severity.

  2024cites this paper
• Reactivation of Trypanosoma cruzi infection in immunosuppressed patients: a systematic review and meta-analysis.

  2024cites this paper
• The epidemiology of Chagas disease in the Americas

  2024cites this paper
• Introducing the NUATEI Consortium: A Mexican Research Program for the Identification of Natural and Synthetic Antimicrobial Compounds for Prevalent Infectious Diseases

  2024cites this paper
• Unraveling the Missing Pieces: Exploring the Gaps in Understanding Chagas Cardiomyopathy

  2024cites this paper
• Synthesis of new trypanocidal agents from the hybridisation of metronidazole and eugenol analogues.

  2024cites this paper
• Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis

  2024cites this paper
• Clinical features of Chagas disease progression and severity

  2024cites this paper
• Exploring the Dimensions of Pre-Clinical Research: 3D Cultures as an Investigative Model of Cardiac Fibrosis in Chagas Disease

  2024cites this paper
• Homologous acetylenic acetogenins from Porcelia macrocarpa R.E. (Fries) displayed potent activity against amastigotes from Trypanosoma cruzi.

  2024cites this paper
• Viable Trypanosoma cruzi cultured from a dead Paratriatoma lecticularia (Hemiptera: Reduviidae) encountered in a large dog kennel environment in south Texas, USA

  2024cites this paper
• INFLUENCE OF ESOPHAGEAL MOTILITY IMPAIRMENT ON UPPER AND LOWER ESOPHAGEAL SPHINCTER PRESSURE IN CHAGAS DISEASE.

  2024cites this paper
• Multimodality Imaging of Chagas Heart Disease: Review and Case Presentation

  2024cites this paper
• Chagas disease is related to structural changes of the gut microbiota in adults with chronic infection (TRIPOBIOME Study)

  2023cites this paper
• Nitazoxanide: A Drug Repositioning Compound with Potential Use in Chagas Disease in a Murine Model

  2023cites this paper
• Elucidating the structure-function attributes of a trypanosomal arginyl-tRNA synthetase.

  2023cites this paper
• Metacyclogenesis as the Starting Point of Chagas Disease

  2023cites this paper
• Chagas Disease: a Review and Perspective on Laboratory Diagnostics in the United States

  2023cites this paper
• Unraveling the role of galectin-3 in cardiac pathology and physiology

  2023cites this paper
• From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease

  2023cites this paper
• Chagas Disease: Medical and ECG Related Findings in an Indigenous Population in Colombia

  2023cites this paper
• At the outer part of the active site in Trypanosoma cruzi glucokinase: The role of phenylalanine 337.

  2023cites this paper
• Narrowing the Relationship between Human CCR5 Gene Polymorphisms and Chagas Disease: Systematic Review and Meta-Analysis

  2023cites this paper
• Clethra fimbriata hexanic extract triggers alteration in the energy metabolism in epimastigotes of Trypanosoma cruzi

  2023influential citation
• The need for bilateral collaborations between the Global North and Global South to mitigate parasitic disease burden in the United States

  2023cites this paper
• Advances in Clinical Practice, Diagnosis and Treatment of Chronic Chagas’ Heart Disease

  2023cites this paper
• Effectiveness of Nitazoxanide and Electrolyzed Oxiding Water in Treating Chagas Disease in a Canine Model

  2023cites this paper
• The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis

  2023cites this paper
• Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels

  2023cites this paper
• Extensible membrane nanotubules mediate attachment of Trypanosoma cruzi epimastigotes under flow

  2023cites this paper
• Lupeol Acetate and α-Amyrin Terpenes Activity against Trypanosoma cruzi: Insights into Toxicity and Potential Mechanisms of Action

  2023cites this paper
• Function and regulation of cGAS-STING signaling in infectious diseases

  2023cites this paper
• Proof of Concept of a Novel Multiepitope Recombinant Protein for the Serodiagnosis of Patients with Chagas Disease

  2023cites this paper
• Knowledge, attitudes, behaviors, and serological status related to Chagas disease among Latin American migrants in Germany: A cross-sectional study in six German cities

  2023cites this paper
• Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease

  2023cites this paper
• Modeling the impact of xenointoxication in dogs to halt Trypanosoma cruzi transmission

  2023cites this paper
• Evaluation of the properties of WHODAS-12 measurements in individuals with Chagas disease in Brazil

  2023cites this paper
• Chronic Trypanosoma cruzi infection activates the TWEAK/Fn14 axis in cardiac myocytes and fibroblasts driving structural and functional changes that affect the heart.

  2023cites this paper
• Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research

  2023influential citation
• Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal–fetal interface

  2023cites this paper
• Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display

  2023cites this paper
• Screening for Chagas disease from the electrocardiogram using a deep neural network

  2023cites this paper
• Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain

  2022cites this paper
• Trypanocidal effect of alcoholic extract of Castanedia santamartensis (Asteraceae) leaves is based on altered mitochondrial function.

  2022cites this paper
• Endemic Thoracic Infections in Latin America and the Caribbean.

  2022cites this paper
• Exhausted PD-1+ TOX+ CD8+ T Cells Arise Only in Long-Term Experimental Trypanosoma cruzi Infection

  2022cites this paper
• Dynamics of Triatoma infestans populations in the Paraguayan Chaco: Population genetic analysis of household reinfestation following vector control

  2022cites this paper
• Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

  2022cites this paper
• New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice

  2022cites this paper
• In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi

  2022cites this paper
• Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.

  2022cites this paper
• Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics

  2022influential citation
• Bowel perforation due to chronic idiopathic megacolon: Case report and literature review

  2022cites this paper
• Insights from the use of erythropoietin in experimental Chagas disease

  2022influential citation
• 4-nitrobenzoylcoumarin potentiates the antiparasitic, anti-inflammatory and cardioprotective effects of benznidazole in a murine model of acute Trypanosoma cruzi infection.

  2022cites this paper
• Effects of Acute and Chronic Trypanosoma cruzi Infection on Pregnancy Outcomes in Mice: Parasite Transmission, Mortality, Delayed Growth, and Organ Damage in Pups.

  2022cites this paper
• Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches

  2022cites this paper
• Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase

  2022cites this paper
• Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure

  2022cites this paper
• T-cell receptor variable region usage in Chagas disease: A systematic review of experimental and human studies

  2022cites this paper
• Trypanosoma cruzi DNA Polymerase β Is Phosphorylated In Vivo and In Vitro by Protein Kinase C (PKC) and Casein Kinase 2 (CK2)

  2022cites this paper
• Nutritional Heart Disease and Cardiomyopathies: JACC Focus Seminar 4/4.

  2022cites this paper
• Transplantation for chagas’ disease: closing the knowledge gap

  2022cites this paper
• 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

  2022cites this paper
• The kinetoplast in the diagnosis of visceral leishmaniasis

  2022cites this paper
• Incentivizing optimal risk map use for Triatoma infestans surveillance in urban environments

  2022cites this paper
• What's new in academic international medicine? The perils of neglecting diseases

  2022cites this paper
• Preliminary chemical characterization of ethanolic extracts from Colombian plants with promising anti - Trypanosoma cruzi activity.

  2021cites this paper
• Neglected cardiovascular diseases and their significance in the Global North

  2021cites this paper
• Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi

  2021influential citation
• Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

  2021cites this paper
• Chagas disease: Immunology of the disease at a glance.

  2021cites this paper
• Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease

  2021cites this paper
• Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy

  2021cites this paper
• Community-based entomological surveillance in three Chagas disease-endemic regions in sub-Andean Bolivia.

  2021cites this paper
• Novel N,N-di-alkylnaphthoimidazolium derivative of β-lapachone impaired Trypanosoma cruzi mitochondrial electron transport system.

  2021cites this paper
• Neoteric strategies for vector control and identification of zoonotic reservoirs

  2021cites this paper
• A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

  2021cites this paper
• Optimization and biological validation of an in vitro assay using the transfected Dm28c/pLacZ Trypanosoma cruzi strain

  2021cites this paper